Similar articles for PMID: 31420498

Year	Number of Results
2004	1
2012	5
2013	2
2014	8
2015	11
2016	13
2017	15
2018	12
2019	16
2020	16
2021	9
2022	6
2023	8
2024	0

1

Tumor Subregion Evolution-Based Imaging Features to Assess Early Response and Predict Prognosis in Oropharyngeal Cancer.

Wu J, Gensheimer MF, Zhang N, Guo M, Liang R, Zhang C, Fischbein N, Pollom EL, Beadle B, Le QT, Li R. Wu J, et al. J Nucl Med. 2020 Mar;61(3):327-336. doi: 10.2967/jnumed.119.230037. Epub 2019 Aug 16. J Nucl Med. 2020. PMID: 31420498 Free PMC article.

2

Early response evaluation using primary tumor and nodal imaging features to predict progression-free survival of locally advanced non-small cell lung cancer.

Zhang N, Liang R, Gensheimer MF, Guo M, Zhu H, Yu J, Diehn M, Loo BW Jr, Li R, Wu J. Zhang N, et al. Theranostics. 2020 Sep 23;10(25):11707-11718. doi: 10.7150/thno.50565. eCollection 2020. Theranostics. 2020. PMID: 33052242 Free PMC article.

3

Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.

Cheng NM, Fang YH, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Lin CY, Liao CT, Yen TC. Cheng NM, et al. J Nucl Med. 2013 Oct;54(10):1703-9. doi: 10.2967/jnumed.112.119289. Epub 2013 Sep 16. J Nucl Med. 2013. PMID: 24042030 Free article.

4

CT and FDG-PET radiologic biomarkers in p16+ oropharyngeal squamous cell carcinoma patients treated with definitive chemoradiotherapy.

Rosen BS, Wilkie JR, Sun Y, Ibrahim M, Casper KA, Miller JE, Chotchutipan T, Stucken CL, Bradford C, Prince MEP, Rosko AJ, Malloy KM, McLean SA, Chinn SB, Shuman AG, Spector ME, Swiecicki PL, Worden FP, Shah JL, Schonewolf CA, Chapman CH, Eisbruch A, Mierzwa ML. Rosen BS, et al. Radiother Oncol. 2021 Feb;155:174-181. doi: 10.1016/j.radonc.2020.10.006. Epub 2020 Oct 16. Radiother Oncol. 2021. PMID: 33069764 Free PMC article.

5

Heterogeneity and irregularity of pretreatment ¹⁸F-fluorodeoxyglucose positron emission tomography improved prognostic stratification of p16-negative high-risk squamous cell carcinoma of the oropharynx.

Cheng NM, Fang YD, Tsan DL, Lee LY, Chang JT, Wang HM, Ng SH, Liao CT, Yang LY, Yen TC. Cheng NM, et al. Oral Oncol. 2018 Mar;78:156-162. doi: 10.1016/j.oraloncology.2018.01.030. Epub 2018 Feb 20. Oral Oncol. 2018. PMID: 29496044

6

Integrating Tumor and Nodal Imaging Characteristics at Baseline and Mid-Treatment Computed Tomography Scans to Predict Distant Metastasis in Oropharyngeal Cancer Treated With Concurrent Chemoradiotherapy.

Wu J, Gensheimer MF, Zhang N, Han F, Liang R, Qian Y, Zhang C, Fischbein N, Pollom EL, Beadle B, Le QT, Li R. Wu J, et al. Int J Radiat Oncol Biol Phys. 2019 Jul 15;104(4):942-952. doi: 10.1016/j.ijrobp.2019.03.036. Epub 2019 Mar 30. Int J Radiat Oncol Biol Phys. 2019. PMID: 30940529 Free PMC article.

7

(18)F-FDG PET/CT to assess response and guide risk-stratified follow-up after chemoradiotherapy for oropharyngeal squamous cell carcinoma.

Bird T, Barrington S, Thavaraj S, Jeannon JP, Lyons A, Oakley R, Simo R, Lei M, Guerrero Urbano T. Bird T, et al. Eur J Nucl Med Mol Imaging. 2016 Jul;43(7):1239-47. doi: 10.1007/s00259-015-3290-4. Epub 2015 Dec 28. Eur J Nucl Med Mol Imaging. 2016. PMID: 26707387

8

Pre-CCRT 18-fluorodeoxyglucose PET-CT improves survival in patients with advanced stages p16-negative oropharyngeal squamous cell carcinoma via accurate radiation treatment planning.

Chen TM, Chen WM, Chen M, Shia BC, Wu SY. Chen TM, et al. J Otolaryngol Head Neck Surg. 2023 Feb 13;52(1):14. doi: 10.1186/s40463-023-00623-y. J Otolaryngol Head Neck Surg. 2023. PMID: 36782296 Free PMC article. Clinical Trial.

9

Value of Intratumoral Metabolic Heterogeneity and Quantitative 18F-FDG PET/CT Parameters to Predict Prognosis in Patients With HPV-Positive Primary Oropharyngeal Squamous Cell Carcinoma.

Mena E, Taghipour M, Sheikhbahaei S, Jha AK, Rahmim A, Solnes L, Subramaniam RM. Mena E, et al. Clin Nucl Med. 2017 May;42(5):e227-e234. doi: 10.1097/RLU.0000000000001578. Clin Nucl Med. 2017. PMID: 28195905 Free PMC article.

10

Prognostic value of pretreatment ¹⁸F-FDG PET/CT and human papillomavirus type 16 testing in locally advanced oropharyngeal squamous cell carcinoma.

Cheng NM, Chang JT, Huang CG, Tsan DL, Ng SH, Wang HM, Liao CT, Lin CY, Hsu CL, Yen TC. Cheng NM, et al. Eur J Nucl Med Mol Imaging. 2012 Nov;39(11):1673-84. doi: 10.1007/s00259-012-2186-9. Epub 2012 Aug 2. Eur J Nucl Med Mol Imaging. 2012. PMID: 22854984

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year